Zebra Capital Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,351
Closed -$299K 84
2022
Q2
$299K Buy
14,351
+1,073
+8% +$20.1K 0.88% 41
2022
Q1
$288K Sell
13,278
-35,210
-73% -$764K 0.66% 58
2021
Q4
$1.35M Sell
48,488
-12,478
-20% -$303K 2.15% 4
2021
Q3
$1.29M Sell
60,966
-48,099
-44% -$902K 1.57% 9
2021
Q2
$1.8M Sell
109,065
-10,054
-8% -$153K 2.11% 3
2021
Q1
$1.49M Buy
119,119
+32,100
+37% +$340K 1.64% 6
2020
Q4
$772K Sell
87,019
-3,011
-3% -$24.5K 0.98% 27
2020
Q3
$584K Buy
90,030
+54,913
+156% +$348K 0.9% 33
2020
Q2
$216K Sell
35,117
-1,410
-4% -$8.65K 0.31% 139
2020
Q1
$246K Sell
36,527
-1,003
-3% -$9.5K 0.4% 107
2019
Q4
$436K Buy
37,530
+22,467
+149% +$254K 0.39% 93
2019
Q3
$155K Sell
15,063
-1,098
-7% -$10.8K 0.17% 200
2019
Q2
$152K Buy
16,161
+204
+1% +$1.57K 0.08% 422
2019
Q1
$112K Buy
15,957
+1,210
+8% +$10.4K 0.06% 412
2018
Q4
$108K Sell
14,747
-3,469
-19% -$29.1K 0.07% 354
2018
Q3
$159K Buy
+18,216
New +$186K 0.07% 394

Other funds holding CCRN

Zebra Capital Management's CCRN Position: Q3 2022 in Review

Zebra Capital Management sold out of Cross Country Healthcare (CCRN) in Q3 2022, closing a stake of 14,351 shares — an estimated $299K sold.

Zebra Capital Management first reported a position in CCRN in Q3 2018 and held it in 16 quarters. The position peaked at $1.8M in Q2 2021. 203 funds tracked by Wall St. Rank hold CCRN as of Q3 2022.

  • Zebra Capital Management reported no remaining Cross Country Healthcare position as of Q3 2022 after selling out during the quarter.
  • Zebra Capital Management sold 14,351 Cross Country Healthcare shares in Q3 2022, an estimated $299K.
  • Zebra Capital Management first reported a position in Cross Country Healthcare in Q3 2018 and held it in 16 quarters.
  • Zebra Capital Management's Cross Country Healthcare position peaked at $1.8M in Q2 2021.
  • 203 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2022.

Based on Zebra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.